KIR2DL3 anticorps (AA 22-245)

N° du produit ABIN7157503

Détail du produit anti-KIR2DL3 anticorps

Antigène: KIR2DL3 (Killer Cell Immunoglobulin-Like Receptor, Two Domains, Long Cytoplasmic Tail, 3 (KIR2DL3))

Épitope: AA 22-245

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp KIR2DL3 est non-conjugé

Application: ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)

Réactivité croisée: Humain

Purification: >95%, Protein G purified

Immunogène: Recombinant Human Killer cell immunoglobulin-like receptor 2DL3 protein (22-245AA)

Isotype: IgG

Information d'application

Indications d'application: Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur KIR2DL3

Antigène: KIR2DL3 (Killer Cell Immunoglobulin-Like Receptor, Two Domains, Long Cytoplasmic Tail, 3 (KIR2DL3))

Autre désignation: KIR2DL3 (KIR2DL3 Produits)

Synonymes: anticorps CD158B2, anticorps CD158b, anticorps GL183, anticorps KIR-023GB, anticorps KIR-K7b, anticorps KIR-K7c, anticorps KIRCL23, anticorps NKAT, anticorps NKAT2, anticorps NKAT2A, anticorps NKAT2B, anticorps p58, anticorps killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3, anticorps KIR2DL3

Sujet:

Background: Receptor on natural killer (NK) cells for HLA-C alleles (HLA-Cw1, HLA-Cw3 and HLA-Cw7). Inhibits the activity of NK cells thus preventing cell lysis.

Aliases: CD158 antigen like family member B2 antibody, CD158 antigen-like family member B2 antibody, CD158b antibody, CD158b2 antibody, GL183 antibody, KI2L3_HUMAN antibody, Killer cell immunoglobulin like receptor two domains long cytoplasmic tail 3 antibody, Killer cell immunoglobulin-like receptor 2DL3 antibody, Killer inhibitory receptor cl 2-3 antibody, Killer inhibitory receptor CL2 3 antibody, KIR 023GB antibody, KIR-023GB antibody, KIR-K7b antibody, KIR-K7c antibody, KIR023GB antibody, KIR2DL3 antibody, KIR2DS5 antibody, KIRCL23 antibody, MHC class I NK cell receptor antibody, Natural killer associated transcript 2 antibody, Natural killer cell inhibitory receptor KIR2DL3 antibody, Natural killer-associated transcript 2 antibody, NKAT antibody, NKAT-2 antibody, NKAT2 antibody, NKAT2a antibody, NKAT2b antibody, p58 antibody, p58 natural killer cell receptor clone CL 6 antibody, p58 natural killer cell receptor clone CL-6 antibody, p58 NK Receptor antibody, p58 NK receptor CL 6 antibody, p58 NK receptor CL-6 antibody, p58.2 MHC class I specific NK receptor antibody, p58.2 MHC class-I-specific NK receptor antibody

UniProt: P43628

Pathways: Cancer Immune Checkpoints